The doctor reached out to The Desert Review suggesting publication of the Protocol he and Dr.
Brian Tyson have refined for their local patients that has been so successful. Fareed also included in
his material what Dr. Zelenko, a pioneer in repurposing medicines for the virus has developed as a
prophylaxis, a preventative subscription.
Also included in the material submitted, is a follow up to Dr. Fareed’s U.S. Senate hearing, “Early
Outpatient Treatment: An Essential Part of a COVID-19 Solution” held November 19 in the Capitol.
Senator Josh Hawley submitted questions to Dr. Fareed to clarify his testimony for the record. Here
is the correspondence between the Senator and Fareed on December 10:
Sen. Hawley: In your testimony, you say that timing is everything when it comes to treatment and
that the best time for outpatient treatment to prevent hospitalization comes when “the virus is in a
period of maximum replication in the upper respiratory tract.” Can you explain what this would mean
for a patient? Would this be five days after exposure, or ten days? Or is it based on symptoms?
Dr. Fareed: The earlier the treatment can be started after the start of the infection, the better and
more rapid the recovery (as well as the reduction in the risk of spread/contagious period). This
would mean that the patient should optimally start the treatment in the first 4 days of the infection
and within five days of exposure. It usually is based on symptoms which start within 1-4 days of viral
entry into the upper respiratory system. Even starting the multi-faceted treatment later (7-10 days
after infection) is also very worthwhile if severe pneumonia necessitating hospitalization has not yet
set in.
Sen. Hawley: In your experience, are patients typically coming in to get treated at this point in their
illness? And if not, what do you think we need to do to encourage high-risk individuals to seek
outpatient treatment and care?
Dr. Fareed: More patients are coming in to get treated or contacting me from afar for treatment
when they can’t receive the treatment in their local communities. Sadly, many infected people and
primary care doctors and doctors in ERs follow the NIH and Dr. Fauci stipulations with no effective
treatments offered. We need to have the NIH/FDA/CDC formally acknowledge the importance of
early treatment with moderately acting, safe anti-virals so readily available. When (if ever) that
happens, everything would improve dramatically. Thank you, Senator Hawley, for all your efforts
and for allowing me to respond to these excellent questions.